000806.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (5 Jul 2023 @ 02:57):

Galaxy Biomedical Investment Co., Ltd. operates in the transmission and distribution, electronic information, and bio-pharmaceutical industries in China...

Stats
Today's Volume	33.86M
Average Volume	8.81M
Market Cap	461.96M
EPS	CNY-0.0663 ( 2023-03-31 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-1.313
ATR14	CNY0.0550 (12.79%)

Volume Correlation

Long: -0.25 (neutral)

Short: -0.56 (weak negative)

Signal:(15.824) Neutral

Galaxy Biomedical Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Galaxy Biomedical Correlation - Currency/Commodity

0.68
( moderate )

0.67
( moderate )

0.00
( neutral )

0.21
( neutral )

-0.47
( neutral )

-0.78
( moderate negative )

Galaxy Biomedical Financials

Annual	2022
Revenue:	CNY1.53B
Gross Profit:	CNY542.64M (35.51 %)
EPS:	CNY-0.310

Q1	2023
Revenue:	CNY246.29M
Gross Profit:	CNY77.89M (31.62 %)
EPS:	CNY-0.0663

Q4	2022
Revenue:	CNY392.16M
Gross Profit:	CNY137.87M (35.16 %)
EPS:	CNY-0.260

Q3	2022
Revenue:	CNY356.06M
Gross Profit:	CNY131.89M (37.04 %)
EPS:	CNY-0.0387

Financial Reports:

No articles found.

Galaxy Biomedical

Galaxy Biomedical Investment Co., Ltd. operates in the transmission and distribution, electronic information, and bio-pharmaceutical industries in China. The company produces and sells various transformer products, such as power, rectifier, and special transformers for use in metal smelting, electrochemistry, and power grid companies; and manufactures and sells electronic components, including displacement sensors, brake resistance boxes, radio frequency components, resistors, potentiometers, and others for use in aviation, aerospace, weapons, ships, AI intelligence, new energy, rail transit, communications, smart grids, instrumentation and other fields. It also offers animal products, and monoclonal antibody and targeted drugs, as well as drugs for the treatment of cancer and other diseases; laboratory equipment; and CRO, CAR-T technology and stem cell technology research and development, malignant cancer immune cell technology, and genetic testing services. The company also exports its products. The company was formerly known as Beihai Yinhe Industry Investment Co., Ltd. and changed its name to Galaxy Biomedical Investment Co., Ltd. in October 2015. Galaxy Biomedical Investment Co., Ltd. was founded in 1993 and is headquartered in Beihai, China.